JNJ-61818549

DRUG2 trials

Sponsors

Janssen Research & Development, LLC

Conditions

Healthy

Phase 1

Pharmacokinetic Study of JNJ-42756493 in Healthy Participants

CompletedNCT02218073

Janssen Research & Development, LLCHealthy

Start: 2014-10-31End: 2014-12-31Updated: 2015-01-08

Study to Assess the Relative Bioavailability of Orally Administered JNJ-42756493 Tablet Versus JNJ-42756493 Capsule in Healthy Participants

CompletedNCT02231489

Janssen Research & Development, LLCHealthy

Start: 2014-09-30End: 2014-11-30Updated: 2014-12-03